Our Board

Kenneth Goulet

Board Chairman

Mr. Goulet is a senior-level health care executive with over 30 years of proven experience in growing and leading large health plan organizations. He has significant experience managing multi-billion dollar P&L and consumer-focused service operations organizations. Mr. Goulet semi-retired in 2015 and has served as an investor, advisor and board member of several growth companies as well as a board director for public companies over the last several years. Previously, Mr. Goulet served as the executive vice president of Anthem Inc., and president of the company’s Commercial and Specialty Business division – the largest Commercial Business Division in the United States. He was responsible for the company’s Local business (including all state presidents, individual on and off exchange business, small group and large group business); National Accounts; and Specialty Products (including dental, vision, life, disability and workers’ compensation). He had P&L accountability for 30 million Medical members and 17.5 million Specialty members. His responsibilities included Strategy, Marketing, Product, Medical Management, Provider Engagement & Contracting and Service Operations. Before joining Anthem, Mr. Goulet spent 23 years at CIGNA Corporation where he held a number of management, sales and operations positions. Mr. Goulet received a Bachelor’s degree in economics from Trinity College in Hartford, Connecticut.

Beau Garverick

Co-founder, Chief Executive Officer, Chief Financial Officer and Board Member

Mr. Garverick has 20 years of healthcare investment banking, corporate development, strategy and investor relations experience. Mr. Garverick most recently served as Senior Vice President, Corporate Development, Strategy, Investor Relations and Integration at WellCare Health Plans, a government-focused managed care company. As head of investor relations, Mr. Garverick was tasked with articulating the company’s strategy, organic and acquisition growth plans and financial and operational results to the investment community. Mr. Garverick also helped lead the $19 billion sale of WellCare to Centene and served as the integration lead for WellCare. Prior to his tenure at WellCare, Mr. Garverick held senior positions within the Corporate Development groups at Coventry and Anthem where he helped source, diligence, negotiate, value and execute numerous acquisitions, divestitures and investments, including Coventry’s acquisition of Children’s Mercy Health Plan and eventual sale to Aetna for approximately $8 billion. While at Anthem, he was instrumental in the proposed $54 billion acquisition of Cigna as well as numerous transactions such as the $4.8 billion sale of Anthem’s PBM to ExpressScripts. Earlier in his career, Mr. Garverick was a member of SG Cowen’s healthcare investment banking group where he executed over 30 transactions, including acquisitions, divestitures, and debt and equity financings. 

Randy Simpson

Co-founder and Board Member

Mr. Simpson has approximately 15 years of healthcare investing, equity research and M&A experience. Most recently, Mr. Simpson served as a Partner and head of healthcare at Glenview Capital Management, a leading alternative asset manager.  Prior to joining Glenview, Mr. Simpson was an equity research analyst at Goldman Sachs, and before that, he spent three years as a generalist in the M&A group at Credit Suisse First Boston. Mr. Simpson served on the Board of Directors of Tenet Healthcare (NYSE: THC) from January 2016 through August 2017 and currently serves as a Director of Longview Acquisition Corp. (NYSE: LGVW), a position he has held since May 2020. He received his M.B.A. in Finance and Accounting from the University of Chicago. Mr. Simpson also earned a J.D. from Georgetown University Law Center and a Bachelor of Arts in Quantitative Economics and Decision Sciences from the University of California, San Diego.

Rhonda Mims

Board Member

Ms. Mims is a senior executive, strategic adviser, and reputation management expert recognized for M&A integration, ESG and Public Affairs. Most recently, Ms. Mims served as an Executive Vice President and Chief Public Affairs Officer for WellCare, a Fortune 200 government-sponsored managed care company with revenues of $30 billion. She managed WellCare’s corporate reputation, including financial and non-financial annual reporting, brand and marketing, government affairs, public policy and corporate communications. Under her leadership the company secured its designation as a Fortune Most Admired Company in 2018 and 2019. Prior to WellCare, Ms. Mims served as the Managing Director of Corporate Social Responsibility at Paul Hastings, LLP, a global law firm and one of the largest in the U.S. serving a diverse client base, including many top financial institutions and Fortune 500 companies. Ms. Mims was also Senior Vice President of Corporate Responsibility/ESG and U.S. Chief Diversity Officer for ING / VOYA Financial. She started her career in the legal profession serving in roles with the United States Department of Justice Environmental Enforcement Section, the National District Attorney Association’s American Prosecutor’s Research Institute and the South Carolina Office of Attorney General. In recognition of her leadership and expertise, Ms. Mims has received numerous honors, including the Silver Anvil Award of Excellence from the Public Relations Society of America, CSR Executive of the Year from PR News, PR Council/Week’s Diversity Distinction Award, Women of Color STEM Corporate Responsibility Award, and the Thurgood Marshall College Fund’s, Corporate Leader Award. She was named to Network Journal’s Top 25 Black Women in Business and SAVOY Magazine’s, Top 100 Blacks in Corporate America five times, most recently in 2020. Ms. Mims earned a Juris Doctor from the University of South Carolina School of Law and earlier a BSc. in Criminal Justice also from the University of South Carolina.  

Stephen Schlegel

Board Member

From August 2005 to February 2021, Mr. Schlegel served as head of Corporate Development at Anthem, Inc., a leading health benefits company. In this capacity, Mr. Schlegel was responsible for leading all the company’s corporate development activities, managing mergers and acquisitions and corporate negotiations. He previously served from 1998 to 2005 as Vice President, Corporate Development and Strategy at Sprint.  Mr. Schlegel also currently is on the board of American Well Corp., where here serves as Chairman of the Audit Committee and is a member of the Compensation Committee. Mr. Schlegel holds a BA in accounting from Loras College and an MBA from the University of Chicago Booth School of Business.


Our Management Team

Beau Garverick

Co-founder, Chief Executive Officer, Chief Financial Officer and Board Member

Mr. Garverick has 20 years of healthcare investment banking, corporate development, strategy and investor relations experience. Mr. Garverick most recently served as Senior Vice President, Corporate Development, Strategy, Investor Relations and Integration at WellCare Health Plans, a government-focused managed care company. As head of investor relations, Mr. Garverick was tasked with articulating the company’s strategy, organic and acquisition growth plans and financial and operational results to the investment community. Mr. Garverick also helped lead the $19 billion sale of WellCare to Centene and served as the integration lead for WellCare. Prior to his tenure at WellCare, Mr. Garverick held senior positions within the Corporate Development groups at Coventry and Anthem where he helped source, diligence, negotiate, value and execute numerous acquisitions, divestitures and investments including Coventry’s acquisition of Children’s Mercy Health Plan and eventual sale to Aetna for approximately $8 billion. While at Anthem, he was instrumental in the proposed $54 billion acquisition of Cigna as well as numerous transactions such as the $4.8 billion sale of Anthem’s PBM to ExpressScripts. Earlier in his career, Mr. Garverick was a member of SG Cowen’s healthcare investment banking group where he executed over 30 transactions, including acquisitions, divestitures, and debt and equity financings. 

Kevin Berena

Head of Corporate Development, Strategy & Investor Relations

Mr. Berena serves as the Head of Corporate Development, Strategy & Investor Relations, overseeing the successful execution of a business combination while also supporting all aspects of the SPAC process. Previously, Mr. Berena worked at Glenview Capital Management, a leading alternative asset manager, where he was a member of Glenview’s healthcare investment team. Prior to Glenview, he was an investment banker at Bank of America Merrill Lynch in its Global Healthcare Coverage Group advising on a variety of complex M&A transactions and capital raises. Mr. Berena earned his MBA from the University of Chicago Booth School of Business with concentrations in Accounting, Finance, Entrepreneurship and Strategic Management. He holds a B.S. in Finance from Indiana University Kelley School of Business where he graduated with High Honors as a Founders Scholar.  

Jason Dunn

Vice President

Mr. Dunn serves as a Vice President, helping diligence and execute a successful business combination. Before joining Orion, Mr. Dunn was Head of Partnerships at Well Dot, Inc., a leading health technology and services company focused on personalized health improvement. Prior to Well, he was an associate at TPG Growth focused mainly on healthcare transactions and an investment banker at Morgan Stanley in its Healthcare Investment Banking Group, advising on both financing and M&A transactions. Mr. Dunn earned his MBA from Harvard Business School. He was a Morehead Cain Scholar at the University of North Carolina at Chapel Hill and graduated Highest Honors with a B.A. in Economics and minors in both Chemistry and Business.